The nation’s leading venture capital trade association is forming a
subgroup to advocate for policies and regulations that it says would
bolster medical innovation in the U.S.
The new group, the Medical Innovation and Competitiveness (MedIC) Coalition, is open to members of the National Venture Capital Association (NVCA) and their portfolio companies, according to a statement from the NVCA.
The new group lists three major goals:
- Bring the importance of medical innovation to the forefront as the country implements healthcare reform
- Establish new and preserve existing incentives for investors and entrepreneurs to develop and commercialize medical innovations in the U.S.
- Achieve broad-based reform of the U.S. Food and Drug Administration
To read the full, original article click on this link: Venture capital group forms medical innovation advocacy organization « MedCity News
Author:
